Kailera Therapeutics Inc (KLRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KLRA | AZN | AMGN | GILD | BMY |
| Company | Kailera Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 20.07 | 185.84 | 330.00 | 130.01 | 58.23 |
| High | 21.25 | 191.50 | 337.63 | 131.34 | 59.61 |
| Low | 19.74 | 184.98 | 329.09 | 129.42 | 57.83 |
| Latest | 21.08 | 189.75 | 337.42 | 130.50 | 59.55 |
| Change | +1.01 | +2.29 | +5.85 | -0.19 | +1.01 |
| % Change | +5.03% | +1.22% | +1.76% | -0.15% | +1.73% |
| Volume | 362,108 | 2,192,669 | 2,000,911 | 4,920,093 | 8,449,744 |
| 20-Day Average Volume | 520,485 | 2,064,313 | 2,821,781 | 6,239,024 | 10,449,487 |
| Previous Close | 20.07 | 187.46 | 331.57 | 130.69 | 58.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.59 | 185.13 | 333.64 | 131.56 | 57.52 |
| 20-Day Raw Stochastic | 30.94% | 84.78% | 58.24% | 29.01% | 77.12% |
| 20-Day Relative Strength | 38.89 | 50.45 | 48.17 | 42.91 | 55.84 |
| Weighted Alpha | N/A | +29.67 | +19.44 | +16.98 | +29.08 |
| Today's Opinion | N/A | 8% Buy | 8% Sell | 24% Sell | 64% Buy |
| Previous Opinion | N/A | 8% Buy | 24% Sell | 24% Sell | 56% Buy |
| Last Month's Opinion | N/A | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.95% since 05/14/26 | +2.59% since 05/14/26 | +0.35% since 05/14/26 | -1.18% since 05/14/26 | +4.90% since 05/14/26 |
| Low | 19.01 on 05/19/26 | 180.55 on 05/15/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 56.14 on 05/15/26 |
| High | 21.77 on 05/15/26 | 191.50 on 05/21/26 | 337.63 on 05/21/26 | 132.80 on 05/15/26 | 59.61 on 05/21/26 |
| 1-Month | |||||
| %Chg | -16.42% since 04/21/26 | -3.08% since 04/21/26 | -2.16% since 04/21/26 | -2.09% since 04/21/26 | +0.27% since 04/21/26 |
| Low | 19.01 on 05/19/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 25.75 on 04/22/26 | 196.65 on 04/22/26 | 350.69 on 04/23/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | N/A since 04/17/26 | -7.08% since 02/20/26 | -9.96% since 02/20/26 | -13.80% since 02/20/26 | -1.83% since 02/20/26 |
| Low | 19.01 on 05/19/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 28.23 on 04/20/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | N/A since 04/17/26 | +4.26% since 11/21/25 | -0.04% since 11/21/25 | +3.05% since 11/21/25 | +28.76% since 11/21/25 |
| Low | 19.01 on 05/19/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 47.58 on 11/24/25 |
| High | 28.23 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,482,218 | 290,733,216 | 178,943,360 | 162,260,784 | 119,542,840 |
| Shares Outstanding, K | 123,678 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -148,955,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | N/A | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | N/A | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | N/A | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.94 | 14.97 | 15.59 | 9.83 |